| Home | Search Abstracts | Browse Sessions | Program Committee | Conference Webcasts | Contact Us |
|
Session 29
Oral Abstracts HIV Infection in Women and Children Wednesday, 10 - 11:45 am Room 2008 |
| Moderators | Diana Gibb Med Res Council, Clin Trials Unit, London, UK Jane Hitti Univ of Washington, Seattle, USA |
| 10:00 am 150 | Genital Expression of Human Papillomavirus Infections in Women with HIV: Predicting Incidence of Vulvar Warts and Vulvar Neoplasia and the Course of Grade 1 Cervical Intraepithelial Neoplasia L S Massad*1, M Silverberg2, G Springer2, C Evans3,10, D J Passaro3,10, H D Strickler4, N Hessol3,5, T M Darragh3,6, J Palefsky3,4, A Levine5,7, H S Sacks9, K Anastos8, H Minkoff6, D H Watts7, and Women's Interagency HIV Study 1Southern Illinois Univ. Sch. of Med., Springfield, USA; 2Johns Hopkins Bloomberg Sch. of Publ. Hlth., Baltimore, MD, USA; 3Univ. of California, San Francisco, USA; 4Albert Einstein Coll. of Med., Bronx, NY, USA; 5Keck Sch. of Med., Univ. of Southern California, Los Angeles, USA; 6Maimonides Med. Ctr., State Univ. of New York, Brooklyn, USA; 7NICHD, NIH, DHHS, Bethesda, MD, USA; 8Montefiore Med. Ctr., Bronx, NY, USA; 9Mt. Sinai Sch. of Med., New York, NY, USA; and 10Univ. of Illinois, Chicago, USA |
| 10:15 am 151 | Effects of Testosterone Administration in HIV-infected Women with Low Weight: A Randomized, Placebo-controlled Study S Dolan*, S Wilkie, N Aliabadi, M Sullivan, N Basgoz, B Davis, and S Grinspoon Massachusetts Gen. Hosp., Boston, USA |
| 10:30 am 152 | Gender Differences in Progression to AIDS and Death from HIV Seroconversion in a Cohort of Intravenous Drug Users from 1986 to 2001 M García de la Hera1, I Ferreros2, J del Amo1, P Garcia de Olalla3, R Muga*4, J del Romero5, R Guerrero6, I Hernandez-Aguado1, S Pérez-Hoyos2, and GEMES (Grupo de Estudio Multicéntrico Español de Seroconvertores) 1Univ. Miguel Hernández, Alicante, Spain; 2Escuela Valenciana de Estudios en Salud, Valencia, Spain; 3Publ. Hlth. Agency, Barcelona, Spain; 4Hosp. Univ. Germans Trias i Pujol, Barcelona, Spain; 5Ctr. Sanitario Sandoval, Madrid, Spain; and 6Red Penitenciaria de Cataluña, Barcelona, Spain |
| 10:45 am 153 | Polymorphisms in the Gene Encoding for CX3CR1 Are Important Determinants of HIV-1-related Disease Progression of Children K Singh*1, M Hughes2, J Chen2, and S A Spector1 1Univ. of California, San Diego, USA and 2Harvard Sch. of Publ. Hlth., Boston, MA, USA |
| 11:00 am 154 | Prognostic Markers of Survival in HIV-infected Children in the CHAP Trial, Zambia F Sinyinza*1, V Mulenga1, K Lishimpi1, G Bhat1, C Chintu1, A Casbard2, S Walker2, L Farrelly2, N Kaganson2, A Nunn2, and D Gibb2 1Univ. Teaching Hosp., Lusaka, Zambia on behalf of the CHAP Trial and 2MRC Clin. Trials Unit, London, UK on behalf of the CHAP Trial |
| 11:15 am 155 | Mortality among Infected and Uninfected Infants Born to HIV-infected Women in Africa: Infants, HIV, and Mortality in Africa Study M L Newell* and Ghent IAS working group on HIV infection in women and children Inst. of Child Hlth., Univ. Coll. London, UK |
| 11:30 am 156LB | A Randomized Placebo-controlled Trial of Cotrimoxazole as Prophylaxis against Opportunistic Infections in Children with HIV-1 Infection in Zambia V Mulenga*1, D Gibb2, G Bhat1, A Walker2, F Sinyinza1, K Lishimpi1, L Farrelly2, R Chileshe1, N Kaganson2, D Mwenya1, J Mwansa1, A Zumla3, S Gillepsie4, A Nunn2, and C Chintu1 1Univ. Teaching Hosp., Lusaka, Zambia; 2MRC Clinical Trials Unit, London, UK; 3Univ. Coll. Hosp., London, UK; and 4Royal Free Hosp., London, UK |